Allergan Inc. (AGN) News Nov 20, 2014, 5:29 p.m.
Post# of 250663
Posted On: 11/20/2014 7:00:30 PM
Allergan Inc. (AGN) News Nov 20, 2014, 5:29 p.m.
MarketWatch News on AGN
Valeant's stock rises after new $2 billion buyback plan announced 12:00 p.m. Today - Tomi Kilgore
La-Z-Boy shares rally after earnings beat targets 4:41 p.m. Nov. 18, 2014 - Sue Chang
Actavis shares outpace buyout target’s gains 12:30 p.m. Nov. 18, 2014 - Russ Britt
S&P 500 registers 42nd record close in skittish market 4:59 p.m. Nov. 17, 2014 - Carla Mozee
Urban Outfitters slides after earnings miss expectations 4:43 p.m. Nov. 17, 2014 - Sue Chang
Valeant says it won’t meet Actavis’s offer 12:18 p.m. Nov. 17, 2014 - Russ Britt
If you're looking big pharma, look no further than Actavis 11:33 a.m. Nov. 17, 2014 - The Trading Deck
Newscast: It's Merger Mania Monday 9:57 a.m. Nov. 17, 2014 - MarketWatch
Actavis to buy Allergan in $66 billion deal 9:35 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Actavis confirms to buy Allergan in $66 billion deal 9:30 a.m. Nov. 17, 2014 - Ciara Linnane
Mon., Nov. 17: Pfizer Stock After Pre-Market Drop 9:24 a.m. Nov. 17, 2014 - MarketWatch
Actavis, Allergan close to a deal 8:33 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Allergan's stock jumps 4.2% premarket after report of potential merger deal 8:22 a.m. Nov. 17, 2014 - Tomi Kilgore
Allergan near a buyout deal worth up to 65 billion 4:30 a.m. Nov. 17, 2014 - MarketWatch
Allergan, Actavis near cash-and-stock deal: WSJ 1:48 p.m. Nov. 16, 2014 - Andria Cheng
Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
Aegon profit hit by mortality changes 2:14 a.m. Nov. 13, 2014 - MarketWatch.com
Drug companies Salix, Intercept reeling after earnings, drama 12:15 p.m. Nov. 7, 2014 - Russ Britt
Ackman urges Allergan to open sale process, negotiate 10:33 a.m. Nov. 7, 2014 - Chelsey Dulaney
Bill Ackman scores critical win in Valeant-Allergan takeover war 4:23 p.m. Nov. 4, 2014 - Russ Britt
Other News on AGN
J&J Seeks FDA Approval for Schizophrenia Treatment - Analyst Blog 4:45 p.m. Today - Zacks.com
Valeant Sets $2 Billion Buyback Plan 12:10 p.m. Today - The Wall Street Journal Interactive Edition
For Allergan Suitors, Unorthodox Alliance Proved Unwieldy 6:48 p.m. Nov. 19, 2014 - The Wall Street Journal Interactive Edition
Valeant Rises After Allergan Snub; Zeltiq In Buy Area 5:14 p.m. Nov. 19, 2014 - Investors Business Daily
AstraZeneca Targets More than $45B in Revenues in 2023 - Analyst Blog 4:20 p.m. Nov. 19, 2014 - Zacks.com
Stock Market News for November 19, 2014 - Market News 10:10 a.m. Nov. 19, 2014 - Zacks.com
Zacks Rank #1 Additions for Wednesday - Tale of the Tape 9:30 a.m. Nov. 19, 2014 - Zacks.com
Can the Uptrend Continue for Allergan (AGN)? - Tale of the Tape 9:30 a.m. Nov. 19, 2014 - Zacks.com
Actavis-Allergan Deal Friendly to Shareholders 8:31 a.m. Nov. 19, 2014 - Barrons.com
The 10-Point: Gerard Baker on the Synagogue Attack, Phone Encryption, Goldman Sachs and More 7:21 a.m. Nov. 19, 2014 - The Wall Street Journal Interactive Edition
Cramer's Mad Money - PPG Industries Will Blow Right Through Its All-Time High (11/18/14) 5:30 a.m. Nov. 19, 2014 - Seeking Alpha
Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook 1:00 a.m. Nov. 19, 2014 - Zacks.com
Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews 1:00 a.m. Nov. 19, 2014 - Zacks.com
Pharma ETFs In Focus On Allergan Takeover Deal 10:04 p.m. Nov. 18, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Why Running With the Bulls Is Profitable but Dangerous 8:10 p.m. Nov. 18, 2014 - TheStreet.com
Goldman Is Tops in Deal Making 7:27 p.m. Nov. 18, 2014 - The Wall Street Journal Interactive Edition
Ackman Drops Push for Allergan Meeting 6:19 p.m. Nov. 18, 2014 - The Wall Street Journal Interactive Edition
Jack Lew, Irish Hero 6:15 p.m. Nov. 18, 2014 - The Wall Street Journal Interactive Edition
The 10-Point: Gerard Baker on the Killing of Peter Kassig, Actavis’ Plan to Buy Allergan, OPEC’s Dilemma and More 7:46 a.m. Nov. 17, 2014 - The Wall Street Journal Interactive Edition
Invest Like Kim Kardashian - Investment Ideas 1:00 a.m. Nov. 17, 2014 - Zacks.com
Press Releases on AGN
Allergan's Semprana and CoLucid's Lasmiditan, Two Novel Acute Migraine Therapies, Will Drive Market Growth Through 2023 1:31 p.m. Today - PR Newswire - PRF
AGN SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Allergan Inc. in Connection With the Fairness of the Sale of the Company to Actavis plc 1:57 p.m. Nov. 19, 2014 - BusinessWire - BZX
Lifshitz & Miller Law Firm Announces Investigation of Allergan, Inc., Baker Hughes Incorporated, ChyronHego Corp., Horizon Lines, Inc., Susquehanna Bancshares, Inc., Swift Energy Company and Valley Financial Corporation 3:48 p.m. Nov. 18, 2014 - PR Newswire - PRF
Cosmetic Implants Market (Source: Polymers, Metals, Ceramics and Biologicals; Application: Breast, Dental, Facial and Others) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2014 - 2020 1:43 p.m. Nov. 18, 2014 - PR Newswire - PRF
Fitch: Allergan Purchase by Actavis Would Pressure Ratings 1:44 p.m. Nov. 17, 2014 - BusinessWire - BZX
Fitch Affirms Actavis at 'BBB-' on Allergan Acquisition Announcement; Outlook Stable 12:20 p.m. Nov. 17, 2014 - BusinessWire - BZX
ALLERGAN SHAREHOLDER ALERT:Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Actavis 11:16 a.m. Nov. 17, 2014 - BusinessWire - BZX
ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:32 a.m. Nov. 17, 2014 - PR Newswire - PRF
Valeant Comments On Allergan Announcement 9:29 a.m. Nov. 17, 2014 - PR Newswire - PRF
Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue 9:15 a.m. Nov. 17, 2014 - PR Newswire - PRF
Physicians Continue to Voice Strong Support for Allergan via Open Letters to the Eye Care Community 9:00 a.m. Nov. 14, 2014 - BusinessWire - BZX
FDA Approves New Styles of Allergan’s NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants 4:50 p.m. Nov. 12, 2014 - BusinessWire - BZX
Allergan Board of Directors Announces Approval of Amendments to Company’s Bylaws 7:02 a.m. Nov. 12, 2014 - BusinessWire - BZX
New Survey Reveals What Women in the U.S. Really Want to Know About BOTOX® Cosmetic (onabotulinumtoxinA) 8:47 a.m. Nov. 11, 2014 - PR Newswire - PRF
Ad hoc: Biofrontera to take over the sales and marketing of Ameluz(R) in Spain from Allergan 3:20 a.m. Nov. 7, 2014 - Thomson Reuters ONE
New Survey Shows Nearly 60% Of Women Say They Would Rather Have A More Youthful Looking Face Than A More Youthful Looking Body(1) 4:25 p.m. Nov. 5, 2014 - PR Newswire - PRF
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology 9:37 a.m. Nov. 5, 2014 - BusinessWire - BZX
Allergan Comments on California Federal Court Ruling in Insider Trading Lawsuit against Valeant & Pershing Square 1:56 p.m. Nov. 4, 2014 - BusinessWire - BZX
Valeant And Pershing Square May Vote At Special Meeting 1:27 p.m. Nov. 4, 2014 - PR Newswire - PRF
Quarterly Financial & Operational Results Release and Dividends - Research Reports on AFLAC, BlackRock, Allergan, Cabot and Cheniere Energy 8:40 a.m. Nov. 3, 2014 - PR Newswire - PRF
MarketWatch News on AGN
Valeant's stock rises after new $2 billion buyback plan announced 12:00 p.m. Today - Tomi Kilgore
La-Z-Boy shares rally after earnings beat targets 4:41 p.m. Nov. 18, 2014 - Sue Chang
Actavis shares outpace buyout target’s gains 12:30 p.m. Nov. 18, 2014 - Russ Britt
S&P 500 registers 42nd record close in skittish market 4:59 p.m. Nov. 17, 2014 - Carla Mozee
Urban Outfitters slides after earnings miss expectations 4:43 p.m. Nov. 17, 2014 - Sue Chang
Valeant says it won’t meet Actavis’s offer 12:18 p.m. Nov. 17, 2014 - Russ Britt
If you're looking big pharma, look no further than Actavis 11:33 a.m. Nov. 17, 2014 - The Trading Deck
Newscast: It's Merger Mania Monday 9:57 a.m. Nov. 17, 2014 - MarketWatch
Actavis to buy Allergan in $66 billion deal 9:35 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Actavis confirms to buy Allergan in $66 billion deal 9:30 a.m. Nov. 17, 2014 - Ciara Linnane
Mon., Nov. 17: Pfizer Stock After Pre-Market Drop 9:24 a.m. Nov. 17, 2014 - MarketWatch
Actavis, Allergan close to a deal 8:33 a.m. Nov. 17, 2014 - Jonathan D. Rockoff
Allergan's stock jumps 4.2% premarket after report of potential merger deal 8:22 a.m. Nov. 17, 2014 - Tomi Kilgore
Allergan near a buyout deal worth up to 65 billion 4:30 a.m. Nov. 17, 2014 - MarketWatch
Allergan, Actavis near cash-and-stock deal: WSJ 1:48 p.m. Nov. 16, 2014 - Andria Cheng
Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
Aegon profit hit by mortality changes 2:14 a.m. Nov. 13, 2014 - MarketWatch.com
Drug companies Salix, Intercept reeling after earnings, drama 12:15 p.m. Nov. 7, 2014 - Russ Britt
Ackman urges Allergan to open sale process, negotiate 10:33 a.m. Nov. 7, 2014 - Chelsey Dulaney
Bill Ackman scores critical win in Valeant-Allergan takeover war 4:23 p.m. Nov. 4, 2014 - Russ Britt
Other News on AGN
J&J Seeks FDA Approval for Schizophrenia Treatment - Analyst Blog 4:45 p.m. Today - Zacks.com
Valeant Sets $2 Billion Buyback Plan 12:10 p.m. Today - The Wall Street Journal Interactive Edition
For Allergan Suitors, Unorthodox Alliance Proved Unwieldy 6:48 p.m. Nov. 19, 2014 - The Wall Street Journal Interactive Edition
Valeant Rises After Allergan Snub; Zeltiq In Buy Area 5:14 p.m. Nov. 19, 2014 - Investors Business Daily
AstraZeneca Targets More than $45B in Revenues in 2023 - Analyst Blog 4:20 p.m. Nov. 19, 2014 - Zacks.com
Stock Market News for November 19, 2014 - Market News 10:10 a.m. Nov. 19, 2014 - Zacks.com
Zacks Rank #1 Additions for Wednesday - Tale of the Tape 9:30 a.m. Nov. 19, 2014 - Zacks.com
Can the Uptrend Continue for Allergan (AGN)? - Tale of the Tape 9:30 a.m. Nov. 19, 2014 - Zacks.com
Actavis-Allergan Deal Friendly to Shareholders 8:31 a.m. Nov. 19, 2014 - Barrons.com
The 10-Point: Gerard Baker on the Synagogue Attack, Phone Encryption, Goldman Sachs and More 7:21 a.m. Nov. 19, 2014 - The Wall Street Journal Interactive Edition
Cramer's Mad Money - PPG Industries Will Blow Right Through Its All-Time High (11/18/14) 5:30 a.m. Nov. 19, 2014 - Seeking Alpha
Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook 1:00 a.m. Nov. 19, 2014 - Zacks.com
Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews 1:00 a.m. Nov. 19, 2014 - Zacks.com
Pharma ETFs In Focus On Allergan Takeover Deal 10:04 p.m. Nov. 18, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Why Running With the Bulls Is Profitable but Dangerous 8:10 p.m. Nov. 18, 2014 - TheStreet.com
Goldman Is Tops in Deal Making 7:27 p.m. Nov. 18, 2014 - The Wall Street Journal Interactive Edition
Ackman Drops Push for Allergan Meeting 6:19 p.m. Nov. 18, 2014 - The Wall Street Journal Interactive Edition
Jack Lew, Irish Hero 6:15 p.m. Nov. 18, 2014 - The Wall Street Journal Interactive Edition
The 10-Point: Gerard Baker on the Killing of Peter Kassig, Actavis’ Plan to Buy Allergan, OPEC’s Dilemma and More 7:46 a.m. Nov. 17, 2014 - The Wall Street Journal Interactive Edition
Invest Like Kim Kardashian - Investment Ideas 1:00 a.m. Nov. 17, 2014 - Zacks.com
Press Releases on AGN
Allergan's Semprana and CoLucid's Lasmiditan, Two Novel Acute Migraine Therapies, Will Drive Market Growth Through 2023 1:31 p.m. Today - PR Newswire - PRF
AGN SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Allergan Inc. in Connection With the Fairness of the Sale of the Company to Actavis plc 1:57 p.m. Nov. 19, 2014 - BusinessWire - BZX
Lifshitz & Miller Law Firm Announces Investigation of Allergan, Inc., Baker Hughes Incorporated, ChyronHego Corp., Horizon Lines, Inc., Susquehanna Bancshares, Inc., Swift Energy Company and Valley Financial Corporation 3:48 p.m. Nov. 18, 2014 - PR Newswire - PRF
Cosmetic Implants Market (Source: Polymers, Metals, Ceramics and Biologicals; Application: Breast, Dental, Facial and Others) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2014 - 2020 1:43 p.m. Nov. 18, 2014 - PR Newswire - PRF
Fitch: Allergan Purchase by Actavis Would Pressure Ratings 1:44 p.m. Nov. 17, 2014 - BusinessWire - BZX
Fitch Affirms Actavis at 'BBB-' on Allergan Acquisition Announcement; Outlook Stable 12:20 p.m. Nov. 17, 2014 - BusinessWire - BZX
ALLERGAN SHAREHOLDER ALERT:Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Acquisition by Actavis 11:16 a.m. Nov. 17, 2014 - BusinessWire - BZX
ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 10:32 a.m. Nov. 17, 2014 - PR Newswire - PRF
Valeant Comments On Allergan Announcement 9:29 a.m. Nov. 17, 2014 - PR Newswire - PRF
Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue 9:15 a.m. Nov. 17, 2014 - PR Newswire - PRF
Physicians Continue to Voice Strong Support for Allergan via Open Letters to the Eye Care Community 9:00 a.m. Nov. 14, 2014 - BusinessWire - BZX
FDA Approves New Styles of Allergan’s NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants 4:50 p.m. Nov. 12, 2014 - BusinessWire - BZX
Allergan Board of Directors Announces Approval of Amendments to Company’s Bylaws 7:02 a.m. Nov. 12, 2014 - BusinessWire - BZX
New Survey Reveals What Women in the U.S. Really Want to Know About BOTOX® Cosmetic (onabotulinumtoxinA) 8:47 a.m. Nov. 11, 2014 - PR Newswire - PRF
Ad hoc: Biofrontera to take over the sales and marketing of Ameluz(R) in Spain from Allergan 3:20 a.m. Nov. 7, 2014 - Thomson Reuters ONE
New Survey Shows Nearly 60% Of Women Say They Would Rather Have A More Youthful Looking Face Than A More Youthful Looking Body(1) 4:25 p.m. Nov. 5, 2014 - PR Newswire - PRF
Ipsen Biopharmaceuticals, Inc. Announces Hire of Donald Pearl as Vice President of Neurology 9:37 a.m. Nov. 5, 2014 - BusinessWire - BZX
Allergan Comments on California Federal Court Ruling in Insider Trading Lawsuit against Valeant & Pershing Square 1:56 p.m. Nov. 4, 2014 - BusinessWire - BZX
Valeant And Pershing Square May Vote At Special Meeting 1:27 p.m. Nov. 4, 2014 - PR Newswire - PRF
Quarterly Financial & Operational Results Release and Dividends - Research Reports on AFLAC, BlackRock, Allergan, Cabot and Cheniere Energy 8:40 a.m. Nov. 3, 2014 - PR Newswire - PRF
(0)
(0)